Product Code: ETC13357914 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Contraceptives Drugs & Devices Market was valued at USD 30.2 Billion in 2024 and is expected to reach USD 45.9 Billion by 2031, growing at a compound annual growth rate of 13.40% during the forecast period (2025-2031).
The Global Contraceptives Drugs & Devices Market is experiencing steady growth due to increasing awareness about family planning, rising prevalence of unintended pregnancies, and the availability of a wide range of contraceptive options. The market is driven by factors such as favorable government initiatives, growing investments in research and development, and the introduction of innovative contraceptive products. Key players in the market are focusing on strategic collaborations, product launches, and acquisitions to expand their market presence. The market is segmented based on product type, distribution channel, and region. With a growing emphasis on sexual health and reproductive rights, the Global Contraceptives Drugs & Devices Market is expected to continue its upward trajectory in the coming years.
The Global Contraceptives Drugs & Devices Market is witnessing significant growth due to increasing awareness about family planning, rising prevalence of unintended pregnancies, and the availability of advanced contraceptive methods. Key trends include a shift towards long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants, as well as the growing popularity of non-hormonal contraceptives. Additionally, the market is seeing a surge in the development of innovative contraceptive technologies, including mobile apps for fertility tracking and male contraceptive options. Opportunities in the market lie in emerging markets with high unmet contraceptive needs, advancements in personalized contraceptive solutions, and increasing investments in research and development for new contraceptive products. Overall, the Global Contraceptives Drugs & Devices Market is poised for continued growth and innovation in the coming years.
Some of the key challenges faced in the Global Contraceptives Drugs & Devices Market include regulatory hurdles and varying approval processes in different countries, cultural and social barriers that impact the adoption of contraceptives, lack of awareness and education about contraceptive options among certain populations, as well as the stigma associated with discussing and using contraceptives. Additionally, there are concerns related to the safety and efficacy of contraceptives, potential side effects, and the need for continuous innovation to develop more convenient and effective contraceptive methods. Market competition, pricing pressures, and limited access to contraceptives in certain regions also pose challenges for companies operating in this market. Overall, navigating these obstacles requires a comprehensive understanding of the diverse factors influencing contraceptive use and market dynamics.
The Global Contraceptives Drugs & Devices Market is primarily driven by factors such as increasing awareness about family planning, rising incidences of unintended pregnancies, and the growing emphasis on population control measures. Additionally, the availability of a wide range of contraceptive options, advancements in contraceptive technology, and government initiatives promoting contraception use are also driving market growth. Furthermore, changing lifestyles, increasing female workforce participation, and the trend towards delayed pregnancies are fueling the demand for contraceptives drugs and devices. The market is also influenced by factors like the expanding healthcare infrastructure, rising disposable incomes, and the increasing prevalence of sexually transmitted infections, all contributing to the overall growth of the contraceptives market globally.
Government policies related to the Global Contraceptives Drugs & Devices Market vary significantly across countries. In many developed nations, governments support access to contraceptives through subsidized programs, public health initiatives, and education campaigns to promote family planning and reduce unintended pregnancies. Some governments also regulate the manufacturing, distribution, and advertising of contraceptive drugs and devices to ensure safety and efficacy. In contrast, certain developing countries may face challenges in implementing comprehensive policies due to limited resources, cultural barriers, or political constraints. Overall, government policies play a crucial role in shaping the landscape of the global contraceptives market by influencing affordability, availability, and awareness of contraceptive products.
The Global Contraceptives Drugs & Devices Market is expected to witness steady growth in the coming years, driven by increasing awareness about family planning and rising demand for effective birth control methods. Technological advancements in contraceptive devices, such as long-acting reversible contraceptives (LARCs) and non-hormonal options, are likely to fuel market expansion. Additionally, the growing prevalence of sexually transmitted infections (STIs) and efforts to prevent unintended pregnancies in developing countries will further propel market growth. However, factors such as social stigma, cultural barriers, and limited access to contraceptives in certain regions may hinder market progress. Overall, the market is anticipated to experience moderate growth due to a combination of factors influencing contraceptive usage and adoption globally.
In the Global Contraceptives Drugs & Devices Market, Asia is anticipated to experience significant growth due to the increasing awareness about family planning and the rising adoption of modern contraceptive methods. North America is expected to dominate the market, driven by the high prevalence of unintended pregnancies and the favorable healthcare infrastructure. Europe is projected to witness steady growth attributed to the presence of key market players and supportive government initiatives promoting contraception. In the Middle East and Africa region, the market growth is hindered by cultural and religious factors restricting the use of contraceptives. Latin America is forecasted to show promising growth due to the growing focus on women`s health and the increasing availability of contraceptive products in the region.
Global Contraceptives Drugs & Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Contraceptives Drugs & Devices Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Contraceptives Drugs & Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Global Contraceptives Drugs & Devices Market - Industry Life Cycle |
3.4 Global Contraceptives Drugs & Devices Market - Porter's Five Forces |
3.5 Global Contraceptives Drugs & Devices Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Contraceptives Drugs & Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Contraceptives Drugs & Devices Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.8 Global Contraceptives Drugs & Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Global Contraceptives Drugs & Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Contraceptives Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Contraceptives Drugs & Devices Market Trends |
6 Global Contraceptives Drugs & Devices Market, 2021 - 2031 |
6.1 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Contraceptive Drugs, 2021 - 2031 |
6.1.3 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Contraceptive Devices, 2021 - 2031 |
6.2 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Male, 2021 - 2031 |
6.2.3 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Female, 2021 - 2031 |
6.3 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.3.3 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Contraceptives Drugs & Devices Market, Revenues & Volume, By Home Use, 2021 - 2031 |
7 North America Contraceptives Drugs & Devices Market, Overview & Analysis |
7.1 North America Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
7.2 North America Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
7.5 North America Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 North America Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Contraceptives Drugs & Devices Market, Overview & Analysis |
8.1 Latin America (LATAM) Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
8.5 Latin America (LATAM) Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8.6 Latin America (LATAM) Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Contraceptives Drugs & Devices Market, Overview & Analysis |
9.1 Asia Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
9.5 Asia Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9.6 Asia Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Contraceptives Drugs & Devices Market, Overview & Analysis |
10.1 Africa Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
10.5 Africa Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10.6 Africa Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Contraceptives Drugs & Devices Market, Overview & Analysis |
11.1 Europe Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
11.5 Europe Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11.6 Europe Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Contraceptives Drugs & Devices Market, Overview & Analysis |
12.1 Middle East Contraceptives Drugs & Devices Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Contraceptives Drugs & Devices Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Contraceptives Drugs & Devices Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Contraceptives Drugs & Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Contraceptives Drugs & Devices Market, Revenues & Volume, By Gender, 2021 - 2031 |
12.5 Middle East Contraceptives Drugs & Devices Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12.6 Middle East Contraceptives Drugs & Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Contraceptives Drugs & Devices Market Key Performance Indicators |
14 Global Contraceptives Drugs & Devices Market - Export/Import By Countries Assessment |
15 Global Contraceptives Drugs & Devices Market - Opportunity Assessment |
15.1 Global Contraceptives Drugs & Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Contraceptives Drugs & Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Contraceptives Drugs & Devices Market Opportunity Assessment, By Gender, 2021 & 2031F |
15.4 Global Contraceptives Drugs & Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
15.5 Global Contraceptives Drugs & Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Contraceptives Drugs & Devices Market - Competitive Landscape |
16.1 Global Contraceptives Drugs & Devices Market Revenue Share, By Companies, 2024 |
16.2 Global Contraceptives Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |